EE03106B1 - Kilega kaetud aeglase vabanemisega peroraalselt manustatav farmatseutiline kompositsioon ja selle kasutamine - Google Patents

Kilega kaetud aeglase vabanemisega peroraalselt manustatav farmatseutiline kompositsioon ja selle kasutamine

Info

Publication number
EE03106B1
EE03106B1 EE9400250A EE9400250A EE03106B1 EE 03106 B1 EE03106 B1 EE 03106B1 EE 9400250 A EE9400250 A EE 9400250A EE 9400250 A EE9400250 A EE 9400250A EE 03106 B1 EE03106 B1 EE 03106B1
Authority
EE
Estonia
Prior art keywords
film
release oral
pharmaceutical composition
slow release
oral pharmaceutical
Prior art date
Application number
EE9400250A
Other languages
English (en)
Estonian (et)
Inventor
K. Kwan Henry
M. Liebowitz Stephen
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of EE03106B1 publication Critical patent/EE03106B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
EE9400250A 1992-10-23 1994-11-21 Kilega kaetud aeglase vabanemisega peroraalselt manustatav farmatseutiline kompositsioon ja selle kasutamine EE03106B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/965,470 US5314697A (en) 1992-10-23 1992-10-23 Stable extended release oral dosage composition comprising loratadine and pseudoephedrine

Publications (1)

Publication Number Publication Date
EE03106B1 true EE03106B1 (et) 1998-08-17

Family

ID=25510010

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400250A EE03106B1 (et) 1992-10-23 1994-11-21 Kilega kaetud aeglase vabanemisega peroraalselt manustatav farmatseutiline kompositsioon ja selle kasutamine

Country Status (28)

Country Link
US (1) US5314697A (xx)
EP (1) EP0665744B1 (xx)
JP (1) JP3580815B2 (xx)
KR (1) KR100283709B1 (xx)
CN (1) CN1038474C (xx)
AT (1) ATE161420T1 (xx)
AU (1) AU676229B2 (xx)
CA (1) CA2147606C (xx)
CZ (1) CZ287687B6 (xx)
DE (1) DE69316023T2 (xx)
DK (1) DK0665744T3 (xx)
EE (1) EE03106B1 (xx)
ES (1) ES2110633T3 (xx)
FI (1) FI112916B (xx)
GR (1) GR3026198T3 (xx)
HK (1) HK1004327A1 (xx)
HU (1) HU220629B1 (xx)
IL (1) IL107354A (xx)
MY (1) MY109090A (xx)
NO (1) NO308771B1 (xx)
NZ (1) NZ257447A (xx)
PH (1) PH29940A (xx)
PL (1) PL172862B1 (xx)
SG (1) SG42947A1 (xx)
SK (1) SK281090B6 (xx)
TW (1) TW251239B (xx)
WO (1) WO1994009761A1 (xx)
ZA (1) ZA937830B (xx)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
AU701042B2 (en) 1995-02-28 1999-01-21 Aventisub Llc Pharmaceutical composition for piperidinoalkanol compounds
US5807579A (en) * 1995-11-16 1998-09-15 F.H. Faulding & Co. Limited Pseudoephedrine combination pharmaceutical compositions
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
PE11399A1 (es) * 1996-10-31 1999-02-09 Schering Corp Combinacion de loratadina y un descongestionante para el tratamiento del asma
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
EE04294B1 (et) * 1997-08-26 2004-06-15 Hoechst Marion Roussel, Inc. Farmatseutiline kompositsioon piperidinoalkanooldekongestandi kombineerimiseks
PE20001070A1 (es) * 1998-09-10 2000-10-19 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
CN1161112C (zh) * 1999-02-23 2004-08-11 株式会社柳韩洋行 含氯雷他定和伪麻黄碱的药物胶囊组合物
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6100274A (en) * 1999-07-07 2000-08-08 Schering Corporation 8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US6114346A (en) * 1999-10-22 2000-09-05 Schering Corporation Treating sleep disorders using desloratadine
WO2001045676A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
SK287684B6 (sk) 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist
US7147870B2 (en) * 2000-01-13 2006-12-12 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
EP1276502A1 (en) * 2000-04-14 2003-01-22 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
AU2002220248A1 (en) * 2000-11-06 2002-05-15 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
WO2003000264A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
WO2004019917A1 (es) * 2002-08-29 2004-03-11 Osmotica Corp. Dispositivo de liberacion de droga que contiene oseltamivir y un antagonista h1
US6720002B2 (en) 2001-07-20 2004-04-13 R.P. Scherer Technologies, Inc. Antihistamine formulations for soft capsule dosage forms
US6863901B2 (en) 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US20040051686A1 (en) * 2002-09-17 2004-03-18 Yuan-Sung Weng Carry-on device having functions of both digital photographing and timing
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
EP1708684A2 (en) * 2003-09-26 2006-10-11 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US20050095288A1 (en) * 2003-11-03 2005-05-05 Andrx Labs, Llc Decongestant and expectorant tablets
EP1700591A4 (en) * 2003-12-01 2011-08-03 Takeda Pharmaceutical PROCESS FOR TREATING SOLID PHARMACEUTICAL PREPARATION PRIOR TO PRINTING AND SOLID PHARMACEUTICAL PREPARATION SUBJECT TO PROCESSING BEFORE PRINTING
US20050266032A1 (en) * 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
SE0401031D0 (sv) 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
WO2006080029A1 (en) * 2005-01-27 2006-08-03 Alembic Limited Extended release formulation of levetiracetam
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
BRPI0711871A2 (pt) * 2006-06-01 2011-12-06 Schering Corp composições farmacêuticas para liberação sustentada de fenilefrina
CN101015519B (zh) * 2007-02-27 2012-03-21 重庆医药工业研究院有限责任公司 一种氯雷他定口服复方药物组合物
WO2008105920A1 (en) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Antihistamine combination
AU2008359725A1 (en) * 2008-07-24 2010-01-28 Handa Pharmaceuticals, Llc Stabilized atypical antipsychotic formulation
EP2448406B1 (en) 2009-02-26 2016-04-20 Relmada Therapeutics, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
CA2690490C (en) 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
CN102160859B (zh) * 2011-02-23 2012-11-07 海南斯达制药有限公司 一种氯雷伪麻复方缓释药物
JP5752578B2 (ja) * 2011-12-09 2015-07-22 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
CN104983708A (zh) * 2015-06-24 2015-10-21 万特制药(海南)有限公司 一种地氯雷他定硫酸伪麻黄碱缓释片及其制备方法
CN108576895B (zh) * 2018-03-06 2021-04-30 特素生物科技（天津）有限公司 缓释营养主食及其制备方法
WO2022023463A1 (en) 2020-07-30 2022-02-03 Faes Farma, S.A. Decongestant drug delivery system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US4601894A (en) * 1985-03-29 1986-07-22 Schering Corporation Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
CN1053570C (zh) * 1987-10-07 2000-06-21 默尔多药物公司 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine

Also Published As

Publication number Publication date
HK1004327A1 (en) 1998-11-20
TW251239B (xx) 1995-07-11
CN1038474C (zh) 1998-05-27
IL107354A0 (en) 1994-01-25
DE69316023T2 (de) 1998-04-23
MY109090A (en) 1996-11-30
ATE161420T1 (de) 1998-01-15
KR950703937A (ko) 1995-11-17
PL172862B1 (pl) 1997-12-31
FI951901A0 (fi) 1995-04-21
FI112916B (fi) 2004-02-13
HU9501143D0 (en) 1995-06-28
SK52295A3 (en) 1997-05-07
CA2147606C (en) 2000-10-10
NZ257447A (en) 1996-09-25
NO951527D0 (no) 1995-04-21
IL107354A (en) 1998-02-08
SG42947A1 (en) 1997-10-17
PH29940A (en) 1996-09-16
CZ287687B6 (en) 2001-01-17
US5314697A (en) 1994-05-24
NO951527L (no) 1995-06-20
WO1994009761A1 (en) 1994-05-11
AU676229B2 (en) 1997-03-06
NO308771B1 (no) 2000-10-30
KR100283709B1 (ko) 2001-03-02
ZA937830B (en) 1994-04-21
JPH08502516A (ja) 1996-03-19
DK0665744T3 (da) 1998-09-07
SK281090B6 (sk) 2000-11-07
JP3580815B2 (ja) 2004-10-27
CZ101495A3 (en) 1996-02-14
EP0665744A1 (en) 1995-08-09
DE69316023D1 (de) 1998-02-05
AU5405094A (en) 1994-05-24
ES2110633T3 (es) 1998-02-16
HUT71682A (en) 1996-01-29
HU220629B1 (hu) 2002-03-28
GR3026198T3 (en) 1998-05-29
EP0665744B1 (en) 1997-12-29
CN1089471A (zh) 1994-07-20
PL308491A1 (en) 1995-08-07
FI951901A (fi) 1995-04-21
CA2147606A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
EE03106B1 (et) Kilega kaetud aeglase vabanemisega peroraalselt manustatav farmatseutiline kompositsioon ja selle kasutamine
AU1687388A (en) Cough/cold mixtures comprising non-sedating antihistamine drugs
US4552899B1 (xx)
EP2196195A3 (en) Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
EP0316434A4 (en) Cough and cold mixtures comprising antihistamine drugs without sedative effects.
MY126555A (en) Oral pharmaceutical extended release dosage form
DK372786D0 (da) Farmaceutiske praeparater af phenindamin
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
AR002275A1 (es) Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
CO5031291A1 (es) Composicion farmaceutica
AU2700488A (en) Pharmaceutical compositions containing dyclonine hcl and phenol
NO993921D0 (no) Medikament mot infertilitet og for ökt fertilitet
DE69026295D1 (de) Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten
DE3878154D1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
ES288168Y (es) Conjunto de impresos para el control en la prescripcion,dis-tribucion, y administracion de medicamentos en centros hos- pitalarios y similares

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name